EU unveils another plan to roll back green rules – POLITICO
The Commission will stress-test the Birds and Habitats Directives in 2026 “taking into account climate change, food security,…
‘Where are we getting the time to do this?’: Why this pharmacist is against prescribing S4 medicines
Grassroots pharmacists worry that the Pharmacy Guild of Australia’s call for S4 and S8 prescribing rights will force…
UK fintech Plum secures e-money licence from City watchdog
Monday 08 December 2025 7:57 am Share Facebook Share on Facebook X Share on Twitter LinkedIn Share on…
Elizabeth Warren Demands Private Credit Stress Test After Big Bankruptcies
US Senator Elizabeth Warren is urging regulators to scrutinize the burgeoning private credit market, warning that implosions of…
Top EU official accuses US of ‘blackmail’ in trade talks – POLITICO
Ribera — who as executive vice president of the Commission ranks second to President Ursula von der Leyen…
Billionaire Haven Switzerland to Reject 50% Inheritance Tax
Swiss voters are poised to reject an inheritance tax proposal targeting super-rich residents, mindful of the risk of…
DeepSeek Rival’s Chinese Backer Monolith Raises $289 Million
Monolith Management, which backed DeepSeek-rival MoonShot AI, has raised about $289 million as it seeks to invest in…
Looser coal-plant ban may threaten Prabowo’s renewables pledge – Regulations
Despite President Prabowo Subianto’s bold pledge to shift Indonesia entirely to renewable energy, a proposal to grant state…
Exclusive | Speaker Johnson Flashes Red on Trump’s Healthcare Push
WASHINGTON—Speaker Mike Johnson (R., La.) cautioned the White House that most House Republicans don’t have an appetite for…
Europe Is Bending the Knee to the US on Tech Policy
Almost everything is on hiatus. The EU AI Act, Digital Services Act, and Digital Markets Act are all…
The EU promised to lead on regulating artificial intelligence. Now it’s hitting pause. – POLITICO
The Artificial Intelligence Act, which took years to negotiate, is not even fully in place yet. Throughout 2025…
FDA Unveils New Path for Approving Drugs for Just One Patient
US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring…